Watch for New "Follow-On" Mealtime Insulin Admelog (Lispro)
April 2018
Admelog (AD-mah-log) will compete with Humalog as a new BRAND of insulin lispro.
This is similar to the situation with Basaglar and Lantus.
Admelog is not a generic...and isn't technically a biosimilar in the U.S. Instead, FDA calls Admelog and Basaglar "follow-on" brands...they use safety and efficacy data from the original brands for faster approval.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote